sglt2 glp-1 news Inhibitors and Receptor Agonists in Cardiovascular–Kidney–Metabolic Syndrome Revolutionizing type 2 diabetes treatment:

To cieka, ktrej monoagonista GLP-1 nie uruchamia

In another study using gestating sows (mature female pigs that have farrowed at least once before the current gestation), Musser et al

The US POINTER and LatAm-FINGERS trials showed that a highly structured lifestyle programme of diet, exercise, cardiovascular health monitoring, and brain-training exercises was more effective than self-guided, flexible changes at improving global cognition scores in adults at risk of cognitive decline and dementia

touchREV Endocrinol 2024;20:7280.ArticlePubMedPMC 15

Glucagon-like Peptide-1 and Glucagon-like Peptide-1 Receptor Agonists Incretin hormones such as glucagon-like peptide-1 (GLP-1) are a group of gut-derived hormones that are released into the bloodstream in response to nutrient intake and regulate postprandial glucose levels by stimulating insulin secretion from pancreatic beta cells, thus contributing to glucose homeostasis [22]